{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,15]],"date-time":"2026-07-15T01:58:47Z","timestamp":1784080727701,"version":"3.55.0"},"reference-count":77,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2020,12,1]],"date-time":"2020-12-01T00:00:00Z","timestamp":1606780800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,12,1]],"date-time":"2020-12-01T00:00:00Z","timestamp":1606780800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Bioorganic Chemistry"],"published-print":{"date-parts":[[2020,12]]},"DOI":"10.1016\/j.bioorg.2020.104393","type":"journal-article","created":{"date-parts":[[2020,10,20]],"date-time":"2020-10-20T01:05:13Z","timestamp":1603155913000},"page":"104393","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":39,"special_numbering":"C","title":["New chalcone-tethered 1,3,5-triazines potentiate the anticancer effect of cisplatin against human lung adenocarcinoma A549 cells by enhancing DNA damage and cell apoptosis"],"prefix":"10.1016","volume":"105","author":[{"given":"Marwa H.","family":"El-Wakil","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sherine N.","family":"Khattab","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amira F.","family":"El-Yazbi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nefertiti","family":"El-Nikhely","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ahmed","family":"Soffar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hosam H.","family":"Khalil","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"2018","key":"10.1016\/j.bioorg.2020.104393_b0005","first-page":"394","article-title":"Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries","volume":"68","author":"Bray","year":"2018","journal-title":"CA. Cancer J. Clin."},{"key":"10.1016\/j.bioorg.2020.104393_b0010","doi-asserted-by":"crossref","first-page":"iv192","DOI":"10.1093\/annonc\/mdy275","article-title":"Metastatic non-small cell lung cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up\u2020","volume":"29","author":"Planchard","year":"2018","journal-title":"Ann. Oncol."},{"key":"10.1016\/j.bioorg.2020.104393_b0015","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1051\/bmdcn\/2017070423","article-title":"A review on the effects of current chemotherapy drugs and natural agents in treating non-small cell lung cancer","volume":"7","author":"Huang","year":"2017","journal-title":"BioMedicine."},{"key":"10.1016\/j.bioorg.2020.104393_b0020","doi-asserted-by":"crossref","first-page":"2027","DOI":"10.1021\/jm00129a001","article-title":"DNA and associated targets for drug design","volume":"32","author":"Hurley","year":"1989","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.bioorg.2020.104393_b0025","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1016\/0090-8258(90)90065-S","article-title":"Chemical enhancement of cisplatin cytotoxicity in a human ovarian and cervical cancer cell line","volume":"38","author":"Boike","year":"1990","journal-title":"Gynecol. Oncol."},{"key":"10.1016\/j.bioorg.2020.104393_b0030","doi-asserted-by":"crossref","first-page":"1016","DOI":"10.1016\/j.juro.2014.09.007","article-title":"Synergistic antitumor effect of triptolide and cisplatin in cisplatin resistant human bladder cancer cells","volume":"193","author":"Ho","year":"2015","journal-title":"J. Urol."},{"key":"10.1016\/j.bioorg.2020.104393_b0035","doi-asserted-by":"crossref","DOI":"10.3390\/ijms20051125","article-title":"Cisplatin synergistically enhances antitumor potency of conditionally replicating adenovirus via p53 dependent or independent pathways in human lung carcinoma","volume":"20","author":"Ali","year":"2019","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.bioorg.2020.104393_b0040","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1016\/S0006-291X(83)80183-1","article-title":"Biochemical studies on the potentiation of antitumor activity of cisplatin by adriamycin","volume":"115","author":"Chuang","year":"1983","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.bioorg.2020.104393_b0045","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1080\/08880010590964381","article-title":"Severe neurotoxicity, ototoxicity and nephrotoxicity following high-dose cisplatin and amifostine","volume":"22","author":"Sastry","year":"2005","journal-title":"Pediatr. Hematol. Oncol."},{"key":"10.1016\/j.bioorg.2020.104393_b0050","doi-asserted-by":"crossref","first-page":"2490","DOI":"10.3390\/toxins2112490","article-title":"Mechanisms of cisplatin nephrotoxicity","volume":"2","author":"Miller","year":"2010","journal-title":"Toxins (Basel)."},{"key":"10.1016\/j.bioorg.2020.104393_b0055","doi-asserted-by":"crossref","unstructured":"A. De Luca, L.J. Parker, W.H. Ang, C. Rodolfo, V. Gabbarini, N.C. Hancock, F. Palone, A.P. Mazzetti, L. Menin, C.J. Morton, M.W. Parker, M. Lo Bello, P.J. Dyson, A structure-based mechanism of cisplatin resistance mediated by glutathione transferase P1-1, Proc. Natl. Acad. Sci. U. S. A. 116 (n.d.) 13943\u201313951. doi:10.1073\/pnas.1903297116.","DOI":"10.1073\/pnas.1903297116"},{"key":"10.1016\/j.bioorg.2020.104393_b0060","doi-asserted-by":"crossref","DOI":"10.1016\/j.bioorg.2019.103236","article-title":"Dual-targeting antitumor conjugates derived from platinum(IV) prodrugs and microtubule inhibitor CA-4 significantly exhibited potent ability to overcome cisplatin resistance","volume":"92","author":"Huang","year":"2019","journal-title":"Bioorg. Chem."},{"key":"10.1016\/j.bioorg.2020.104393_b0065","doi-asserted-by":"crossref","first-page":"621","DOI":"10.1124\/pr.58.3.10","article-title":"Theoretical basis, experimental design, and computerized simulation of synergism and antagonism in drug combination studies","volume":"58","author":"Chou","year":"2006","journal-title":"Pharmacol. Rev."},{"key":"10.1016\/j.bioorg.2020.104393_b0070","doi-asserted-by":"crossref","first-page":"9426","DOI":"10.1021\/acsami.6b16844","article-title":"Synergistic cisplatin\/doxorubicin combination chemotherapy for multidrug-resistant cancer via polymeric nanogels targeting delivery","volume":"9","author":"Wu","year":"2017","journal-title":"ACS Appl. Mater. Interfaces."},{"key":"10.1016\/j.bioorg.2020.104393_b0075","doi-asserted-by":"crossref","first-page":"981","DOI":"10.1038\/sj.bjc.6690452","article-title":"Mechanisms of synergism between cisplatin and gemcitabine in ovarian and non small-cell lung cancer cell lines","volume":"80","author":"Van Moorsel","year":"1999","journal-title":"Br. J. Cancer."},{"key":"10.1016\/j.bioorg.2020.104393_b0080","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1007\/s101470050096","article-title":"B.-181339 O.C.S. Group, Paclitaxel-cisplatin combination in advanced ovarian cancer: a phase II study","volume":"5","author":"Sugiyama","year":"2000","journal-title":"Int. J. Clin. Oncol."},{"key":"10.1016\/j.bioorg.2020.104393_b0085","first-page":"205","article-title":"Combination of osthole and cisplatin against rhabdomyosarcoma TE671 cells yielded additive pharmacologic interaction by means of isobolographic analysis","volume":"38","author":"Jarzab","year":"2018","journal-title":"Anticancer Res."},{"key":"10.1016\/j.bioorg.2020.104393_b0090","doi-asserted-by":"crossref","first-page":"4509","DOI":"10.7150\/jca.31045","article-title":"Combination of quercetin and cisplatin enhances apoptosis in OSCC cells by downregulating xIAP through the NF-\u03baB pathway","volume":"10","author":"Li","year":"2019","journal-title":"J. Cancer."},{"key":"10.1016\/j.bioorg.2020.104393_b0095","doi-asserted-by":"crossref","first-page":"13","DOI":"10.3892\/or.2015.4371","article-title":"Curcumin improves the efficacy of cisplatin by targeting cancer stem-like cells through p21 and cyclin D1-mediated tumour cell inhibition in non-small cell lung cancer cell lines","volume":"35","author":"Baharuddin","year":"2016","journal-title":"Oncol. Rep."},{"key":"10.1016\/j.bioorg.2020.104393_b0100","doi-asserted-by":"crossref","first-page":"2005","DOI":"10.1248\/bpb.b17-00457","article-title":"Caffeine has a synergistic anticancer effect with cisplatin via inhibiting fanconi anemia group D2 protein monoubiquitination in hepatocellular carcinoma cells","volume":"40","author":"Oda","year":"2017","journal-title":"Biol. Pharm. Bull."},{"key":"10.1016\/j.bioorg.2020.104393_b0105","doi-asserted-by":"crossref","first-page":"340","DOI":"10.1590\/S0100-40422003000300010","article-title":"Synergism between dipyridamole and cisplatin in human breast cancer cells in vitro","volume":"26","author":"Perussi","year":"2003","journal-title":"Quim. Nova."},{"key":"10.1016\/j.bioorg.2020.104393_b0110","first-page":"5159","article-title":"Synergistic anticancer activity of thiazolo[5,4-b]quinoline derivative D3CLP in combination with cisplatin in human cervical cancer cells","volume":"32","author":"Gonzalez-Sanchez","year":"2012","journal-title":"Anticancer Res."},{"key":"10.1016\/j.bioorg.2020.104393_b0115","doi-asserted-by":"crossref","first-page":"3625","DOI":"10.1007\/s11033-019-04605-0","article-title":"Comparison of the effect of three different topoisomerase II inhibitors combined with cisplatin in human glioblastoma cells sensitized with double strand break repair inhibitors","volume":"46","author":"Macieja","year":"2019","journal-title":"Mol. Biol. Rep."},{"key":"10.1016\/j.bioorg.2020.104393_b0120","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1016\/j.dnarep.2016.03.009","article-title":"Small molecule activation of apurinic\/apyrimidinic endonuclease 1 reduces DNA damage induced by cisplatin in cultured sensory neurons","volume":"41","author":"Georgiadis","year":"2016","journal-title":"DNA Repair (Amst)."},{"key":"10.1016\/j.bioorg.2020.104393_b0125","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1016\/j.etap.2013.12.002","article-title":"WP 631 and Epo B synergize in SKOV-3 human ovarian cancer cells","volume":"37","author":"Marczak","year":"2014","journal-title":"Environ. Toxicol. Pharmacol."},{"key":"10.1016\/j.bioorg.2020.104393_b0130","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1016\/j.ejmech.2017.09.035","article-title":"1,3,5-Triazines: a promising scaffold for anticancer drugs development","volume":"142","author":"Cascioferro","year":"2017","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.bioorg.2020.104393_b0135","doi-asserted-by":"crossref","first-page":"368","DOI":"10.1016\/j.ygyno.2003.09.017","article-title":"Oral altretamine used as salvage therapy in recurrent ovarian cancer","volume":"92","author":"Chan","year":"2004","journal-title":"Gynecol. Oncol."},{"key":"10.1016\/j.bioorg.2020.104393_b0140","doi-asserted-by":"crossref","first-page":"969","DOI":"10.1016\/j.cellsig.2015.02.006","article-title":"Decitabine represses osteoclastogenesis through inhibition of RANK and NF-\u03baB","volume":"27","author":"Guan","year":"2015","journal-title":"Cell. Signal."},{"key":"10.1016\/j.bioorg.2020.104393_b0145","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1016\/j.leukres.2016.04.003","article-title":"Azacitidine versus decitabine in patients with refractory anemia with excess blast\u2014Results of multicenter study","volume":"45","author":"Salim","year":"2016","journal-title":"Leuk. Res."},{"key":"10.1016\/j.bioorg.2020.104393_b0150","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1158\/1535-7163.MCT-11-0474","article-title":"Identification and characterization of NVP-BKM120, an orally available pan-class I PI3-kinase inhibitor","volume":"11","author":"Maira","year":"2012","journal-title":"Mol. Cancer Ther."},{"key":"10.1016\/j.bioorg.2020.104393_b0155","doi-asserted-by":"crossref","first-page":"1638","DOI":"10.1111\/j.1349-7006.2007.00580.x","article-title":"ZSTK474 is an ATP-competitive inhibitor of class I phosphatidylinositol 3 kinase isoforms","volume":"98","author":"Kong","year":"2007","journal-title":"Cancer Sci."},{"key":"10.1016\/j.bioorg.2020.104393_b0160","doi-asserted-by":"crossref","first-page":"1815","DOI":"10.1016\/j.bmc.2006.11.028","article-title":"Synthesis and antitumor evaluation of a novel series of triaminotriazine derivatives","volume":"15","author":"Zheng","year":"2007","journal-title":"Bioorg. Med. Chem."},{"key":"10.1016\/j.bioorg.2020.104393_b0165","doi-asserted-by":"crossref","first-page":"646","DOI":"10.1016\/j.jscs.2014.02.002","article-title":"An efficient synthesis of new thiazolidin-4-one fused s-triazines as potential antimicrobial and anticancer agents","volume":"18","author":"Patel","year":"2014","journal-title":"J. Saudi Chem. Soc."},{"key":"10.1016\/j.bioorg.2020.104393_b0170","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1007\/s40242-014-3253-5","article-title":"Design, synthesis and anticancer activity of novel 6-(aminophenyl)-2,4-bismorpholino-1,3,5-triazine derivatives bearing arylmethylene hydrazine moiety","volume":"30","author":"Huang","year":"2014","journal-title":"Chem. Res. Chinese Univ."},{"key":"10.1016\/j.bioorg.2020.104393_b0175","doi-asserted-by":"crossref","first-page":"5851","DOI":"10.1038\/s41598-017-05934-5","article-title":"Design and discovery of novel monastrol-1,3,5-triazines as potent anti-breast cancer agent via attenuating Epidermal Growth Factor Receptor tyrosine kinase","volume":"7","author":"Srivastava","year":"2017","journal-title":"Sci. Rep."},{"key":"10.1016\/j.bioorg.2020.104393_b0180","first-page":"7","article-title":"Design, synthesis and molecular modeling of new 1,3,5-triazine derivatives as anticancer agents","volume":"11","author":"Marwa","year":"2019","journal-title":"Der Pharma Chem."},{"key":"10.1016\/j.bioorg.2020.104393_b0185","doi-asserted-by":"crossref","first-page":"7762","DOI":"10.1021\/acs.chemrev.7b00020","article-title":"Chalcone: a privileged structure in medicinal chemistry","volume":"117","author":"Zhuang","year":"2017","journal-title":"Chem. Rev."},{"key":"10.1016\/j.bioorg.2020.104393_b0190","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1016\/j.bioorg.2015.02.007","article-title":"DNA-binding affinity and anticancer activity of \u03b2-carboline\u2013chalcone conjugates as potential DNA intercalators: molecular modelling and synthesis","volume":"59","author":"Shankaraiah","year":"2015","journal-title":"Bioorg. Chem."},{"key":"10.1016\/j.bioorg.2020.104393_b0195","doi-asserted-by":"crossref","first-page":"1004","DOI":"10.1111\/j.1582-4934.2009.00697.x","article-title":"The mitochondrial death pathway: a promising therapeutic target in diseases","volume":"13","author":"Gupta","year":"2009","journal-title":"J. Cell. Mol. Med."},{"key":"10.1016\/j.bioorg.2020.104393_b0200","doi-asserted-by":"crossref","first-page":"1045","DOI":"10.1002\/jor.22050","article-title":"Flavokawain B, a kava chalcone, induces apoptosis in synovial sarcoma cell lines","volume":"30","author":"Sakai","year":"2012","journal-title":"J. Orthop. Res."},{"key":"10.1016\/j.bioorg.2020.104393_b0205","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2019.111687","article-title":"Recent advances in \u03b1, \u03b2-unsaturated carbonyl compounds as mitochondrial toxins","volume":"183","author":"Hossain","year":"2019","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.bioorg.2020.104393_b0210","doi-asserted-by":"crossref","first-page":"7228","DOI":"10.1021\/jm901278z","article-title":"Structure - Activity relationship studies of chalcone leading to 3-hydroxy-4,3\u2032,4\u2032,5\u2032-tetramethoxychalcone and its analogues as potent nuclear factor \u03baB inhibitors and their anticancer activities","volume":"52","author":"Srinivasan","year":"2009","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.bioorg.2020.104393_b0215","doi-asserted-by":"crossref","first-page":"3916","DOI":"10.1016\/j.bmcl.2010.05.016","article-title":"Synthesis and biological evaluation of indolyl chalcones as antitumor agents","volume":"20","author":"Kumar","year":"2010","journal-title":"Bioorg. Med. Chem. Lett."},{"key":"10.1016\/j.bioorg.2020.104393_b0220","doi-asserted-by":"crossref","first-page":"3320","DOI":"10.1016\/j.bmcl.2013.03.106","article-title":"Chalcones, inhibitors for topoisomerase I and cathepsin B and L, as potential anti-cancer agents","volume":"23","author":"Kim","year":"2013","journal-title":"Bioorg. Med. Chem. Lett."},{"key":"10.1016\/j.bioorg.2020.104393_b0225","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1016\/j.ejmech.2014.11.014","article-title":"In vitro and in vivo anti-glioma activity of a chalcone-quinoxaline hybrid","volume":"90","author":"Loch-Neckel","year":"2015","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.bioorg.2020.104393_b0230","doi-asserted-by":"crossref","first-page":"2969","DOI":"10.1016\/j.bmcl.2018.07.003","article-title":"The synthetic chalcone derivative 2-hydroxy-3\u2032,5,5\u2032-trimethoxychalcone induces unfolded protein response-mediated apoptosis in A549 lung cancer cells","volume":"28","author":"Gil","year":"2018","journal-title":"Bioorg. Med. Chem. Lett."},{"key":"10.1016\/j.bioorg.2020.104393_b0235","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1080\/14756366.2019.1690479","article-title":"Synthesis, biological evaluation, and molecular modelling of new naphthalene-chalcone derivatives as potential anticancer agents on MCF-7 breast cancer cells by targeting tubulin colchicine binding site","volume":"35","author":"Wang","year":"2020","journal-title":"J. Enzyme Inhib. Med. Chem."},{"key":"10.1016\/j.bioorg.2020.104393_b0240","doi-asserted-by":"crossref","first-page":"1956","DOI":"10.3390\/molecules23081956","article-title":"Synthesis of new 1,3,5-triazine-based 2-pyrazolines as potential anticancer agents","volume":"23","author":"Moreno","year":"2018","journal-title":"Molecules."},{"key":"10.1016\/j.bioorg.2020.104393_b0245","doi-asserted-by":"crossref","DOI":"10.1016\/j.bioorg.2019.103089","article-title":"Discovery of a novel DNA binding agent via design and synthesis of new thiazole hybrids and fused 1,2,4-triazines as potential antitumor agents: computational, spectrometric and in silico studies","volume":"90","author":"El-Wakil","year":"2019","journal-title":"Bioorg. Chem."},{"key":"10.1016\/j.bioorg.2020.104393_b0250","doi-asserted-by":"crossref","first-page":"103013","DOI":"10.1016\/j.bioorg.2019.103013","article-title":"Design, synthesis and molecular modeling studies of new series of s-triazine derivatives as antimicrobial agents against multi-drug resistant clinical isolates","volume":"89","author":"Haiba","year":"2019","journal-title":"Bioorg. Chem."},{"key":"10.1016\/j.bioorg.2020.104393_b0255","doi-asserted-by":"crossref","first-page":"10676","DOI":"10.1039\/C8NJ01483C","article-title":"Synthesis and characterization of novel dimeric s-triazine derivatives as potential anti-bacterial agents against MDR clinical isolates","volume":"42","author":"Ramadan","year":"2018","journal-title":"New J. Chem."},{"key":"10.1016\/j.bioorg.2020.104393_b0260","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1186\/s13065-017-0267-3","article-title":"Synthesis, characterization and evaluation of 1,3,5-triazine aminobenzoic acid derivatives for their antimicrobial activity","volume":"11","author":"Al-Zaydi","year":"2017","journal-title":"Chem. Cent. J."},{"key":"10.1016\/j.bioorg.2020.104393_b0265","first-page":"4175","article-title":"Anti-breast cancer activity of selected 1,3,5-triazines via modulation of EGFR-TK","volume":"18","author":"Yan","year":"2018","journal-title":"Mol. Med. Rep."},{"key":"10.1016\/j.bioorg.2020.104393_b0270","doi-asserted-by":"crossref","first-page":"6886","DOI":"10.1016\/j.bmcl.2013.09.087","article-title":"Design, synthesis and in vitro anticancer evaluation of 4,6-diamino-1,3,5-triazine-2-carbohydrazides and -carboxamides","volume":"23","author":"Kothayer","year":"2013","journal-title":"Bioorg. Med. Chem. Lett."},{"key":"10.1016\/j.bioorg.2020.104393_b0275","first-page":"914","article-title":"Interaction of chalcones with CT-DNA by spectrophotometric analysis and theoretical simulations","volume":"39","author":"Zarate","year":"2016","journal-title":"Quim. Nova."},{"key":"10.1016\/j.bioorg.2020.104393_b0280","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1016\/j.bioorg.2014.03.004","article-title":"Synthesis and evaluation of novel isoxazolyl chalcones as potential anticancer agents","volume":"54","author":"Wan","year":"2014","journal-title":"Bioorg. Chem."},{"key":"10.1016\/j.bioorg.2020.104393_b0285","doi-asserted-by":"crossref","first-page":"506","DOI":"10.1007\/s12010-019-03078-y","article-title":"Kinetic and thermodynamic investigation of human serum albumin interaction with anticancer glycine derivative of platinum complex by using spectroscopic methods and molecular docking","volume":"190","author":"Shiekhzadeh","year":"2020","journal-title":"Appl. Biochem. Biotechnol."},{"key":"10.1016\/j.bioorg.2020.104393_b0290","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1002\/jps.2600820102","article-title":"In the search for new anticancer drugs. XXIV: Synthesis and anticancer activity of amino acids and dipeptides containing the 2-chloroethyl- and [N\u2032-(2-chloroethyl)-N\u2032-nitroso]-aminocarbonyl groups","volume":"82","author":"Sosnovsky","year":"1993","journal-title":"J. Pharm. Sci."},{"key":"10.1016\/j.bioorg.2020.104393_b0295","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1007\/s00775-014-1221-7","article-title":"Phosphonomethyl iminodiacetic acid-conjugated cobalt oxide nanoparticles liberate Co++ ion-induced stress associated activation of TNF-\u03b1\/p38 MAPK\/caspase 8-caspase 3 signaling in human leukemia cells","volume":"20","author":"Chattopadhyay","year":"2015","journal-title":"JBIC J. Biol. Inorg. Chem."},{"key":"10.1016\/j.bioorg.2020.104393_b0300","doi-asserted-by":"crossref","first-page":"725","DOI":"10.1002\/cmdc.201700770","article-title":"1,3,5-Triazino peptide derivatives: synthesis, characterization, and preliminary antileishmanial activity","volume":"13","author":"Khattab","year":"2018","journal-title":"ChemMedChem."},{"key":"10.1016\/j.bioorg.2020.104393_b0305","doi-asserted-by":"crossref","first-page":"15976","DOI":"10.3390\/molecules200915976","article-title":"Synthesis and preliminary biological evaluation of 1,3,5-triazine amino acid derivatives to study their MAO inhibitors","volume":"20","author":"Khattab","year":"2015","journal-title":"Molecules."},{"key":"10.1016\/j.bioorg.2020.104393_b0310","doi-asserted-by":"crossref","DOI":"10.1007\/s00044-012-0192-x","article-title":"Synthesis of some (E)-6-[2-(furan-2-yl)ethenyl]-1,2,4-triazin-5-ones and their biological evaluation as antitumor agents","volume":"22","author":"Ashour","year":"2013","journal-title":"Med. Chem. Res."},{"key":"10.1016\/j.bioorg.2020.104393_b0315","doi-asserted-by":"crossref","unstructured":"J. van Meerloo, G.J.L. Kaspers, J. Cloos, Cell sensitivity assays: the MTT assay BT - cancer cell culture: methods and protocols, in: I.A. Cree (Ed.), Humana Press, Totowa, NJ, 2011: pp. 237\u2013245. doi:10.1007\/978-1-61779-080-5_20.","DOI":"10.1007\/978-1-61779-080-5_20"},{"key":"10.1016\/j.bioorg.2020.104393_b0320","doi-asserted-by":"crossref","first-page":"1289","DOI":"10.1158\/1535-7163.MCT-11-0058","article-title":"Chemotherapy dosing schedule influences drug resistance development in ovarian cancer","volume":"10","author":"De Souza","year":"2011","journal-title":"Mol. Cancer Ther."},{"key":"10.1016\/j.bioorg.2020.104393_b0325","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/0065-2571(84)90007-4","article-title":"Quantitative analysis of dose-effect relationships: the combined effects of multiple drugs or enzyme inhibitors","volume":"22","author":"Chou","year":"1984","journal-title":"Adv. Enzyme Regul."},{"key":"10.1016\/j.bioorg.2020.104393_b0330","doi-asserted-by":"crossref","first-page":"450","DOI":"10.1016\/0165-6147(83)90490-X","article-title":"Analysis of combined drug effects: a new look at a very old problem","volume":"4","author":"Chou","year":"1983","journal-title":"Trends Pharmacol. Sci."},{"key":"10.1016\/j.bioorg.2020.104393_b0335","doi-asserted-by":"crossref","first-page":"3652","DOI":"10.1093\/nar\/29.17.3652","article-title":"Characterization of a multi-functional metal-mediated nuclease by MALDI-TOF mass spectrometry","volume":"29","author":"Puapaiboon","year":"2001","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.bioorg.2020.104393_b0340","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1007\/s00216-012-5790-4","article-title":"Molecular beacon probes for the detection of cisplatin-induced DNA damage","volume":"403","author":"Shire","year":"2012","journal-title":"Anal. Bioanal. Chem."},{"key":"10.1016\/j.bioorg.2020.104393_b0345","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/j.trac.2014.05.010","article-title":"Detecting UV-induced nucleic-acid damage","volume":"61","author":"El-Yazbi","year":"2014","journal-title":"TrAC Trends Anal. Chem."},{"key":"10.1016\/j.bioorg.2020.104393_b0350","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1016\/j.saa.2016.07.054","article-title":"Design, synthesis and DNA-binding study of some novel morpholine linked thiazolidinone derivatives","volume":"173","author":"War","year":"2017","journal-title":"Spectrochim. Acta Part A Mol. Biomol. Spectrosc."},{"key":"10.1016\/j.bioorg.2020.104393_b0355","doi-asserted-by":"crossref","first-page":"406","DOI":"10.1016\/j.saa.2012.06.044","article-title":"Binding studies of the antidiabetic drug, metformin to calf thymus DNA using multispectroscopic methods","volume":"97","author":"Shahabadi","year":"2012","journal-title":"Spectrochim. Acta Part A Mol. Biomol. Spectrosc."},{"key":"10.1016\/j.bioorg.2020.104393_b0360","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1016\/j.aca.2013.04.068","article-title":"Terbium fluorescence as a sensitive, inexpensive probe for UV-induced damage in nucleic acids","volume":"786","author":"El-Yazbi","year":"2013","journal-title":"Anal. Chim. Acta."},{"key":"10.1016\/j.bioorg.2020.104393_b0365","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1016\/j.aca.2017.09.036","article-title":"A luminescent probe of mismatched DNA hybridization: location and number of mismatches","volume":"994","author":"El-Yazbi","year":"2017","journal-title":"Anal. Chim. Acta."},{"key":"10.1016\/j.bioorg.2020.104393_b0370","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1016\/j.jpba.2018.05.019","article-title":"Probing DNA damage induced by common antiviral agents using multiple analytical techniques","volume":"157","author":"El-Yazbi","year":"2018","journal-title":"J. Pharm. Biomed. Anal."},{"key":"10.1016\/j.bioorg.2020.104393_b0375","unstructured":"2016. Molecular Operating Environment (MOE), Chemical Computing Group Inc.: Montreal, QC, Canada, No Title, (n.d.)."},{"key":"10.1016\/j.bioorg.2020.104393_b0380","doi-asserted-by":"crossref","DOI":"10.1016\/j.bioorg.2019.103432","article-title":"Synthesis of naphthalimide-carborane and metallacarborane conjugates: Anticancer activity, DNA binding ability","volume":"94","author":"Nekvinda","year":"2020","journal-title":"Bioorg. Chem."},{"key":"10.1016\/j.bioorg.2020.104393_b0385","doi-asserted-by":"crossref","first-page":"465","DOI":"10.3389\/fphar.2016.00465","article-title":"Anti-proliferative and apoptosis-inducing effect of theabrownin against non-small cell lung adenocarcinoma A549 cells","volume":"7","author":"Wu","year":"2016","journal-title":"Front. Pharmacol."}],"container-title":["Bioorganic Chemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0045206820316916?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0045206820316916?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,23]],"date-time":"2025-09-23T08:10:34Z","timestamp":1758615034000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0045206820316916"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,12]]},"references-count":77,"alternative-id":["S0045206820316916"],"URL":"https:\/\/doi.org\/10.1016\/j.bioorg.2020.104393","relation":{},"ISSN":["0045-2068"],"issn-type":[{"value":"0045-2068","type":"print"}],"subject":[],"published":{"date-parts":[[2020,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"New chalcone-tethered 1,3,5-triazines potentiate the anticancer effect of cisplatin against human lung adenocarcinoma A549 cells by enhancing DNA damage and cell apoptosis","name":"articletitle","label":"Article Title"},{"value":"Bioorganic Chemistry","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bioorg.2020.104393","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"104393"}}